At the Outsourcing in Clinical Trials Conference in New England, the CBP warned attendees of the common legal pitfalls researchers make in transporting material for clinical research. Credit: Jonathan Weiss via Shutterstock.

The incorrect transport of biological materials opens the US up to the risk of infectious disease and biological threats, says Sean Smith, a biological threat exclusion coordinator at the US Customs and Border Protection (CBP).

Last year, the agency seized 549,238lb of drugs. While narcotics and illegal substances made up the majority of this number, other drugs accounted for 107,510lb.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

“We are seeing more and more non-compliant biological materials coming in,” said Smith at a talk at the Outsourcing in Clinical Trials Conference in New England on 23-24 October.

Many of the non-compliant materials are research materials and some finished products, said Baljeet Kaur, the agriculture operations manager from CBP. On the research material side, these items are often regulated by multiple agencies, she added.

Confiscated items have included plasmids, preserved animal tissue, and cryo-containers, said Kaur. Often people have legitimate uses for these materials, but if people transport them without the correct paperwork, the CBP must assess them as potential threats, said Smith.

The CBP has agricultural and biological programmes to keep dangerous biological threats out of the US for national security reasons.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

A common misconception is that people rule out certain products as regulated by the US Department of Agriculture (USDA). “Just because the US Food and Drug Administration (FDA) has approved something it does not mean it’s approved to come into the country. A lot of products that we see are regulated by more than one agency, and they all have to be satisfied,” said Smith.

He listed the primate material as something that is often incorrectly transported due to this misconception. Primate, fish and wildlife products require a declaration before the product has left the country.

The Department of Transportation also has strict requirements on the importation of certain materials, added Smith. To import biological materials, individuals should sign up for a permit from the USDA and/or the Centers for Disease Control and Prevention (CDC), said Smith. Medications can only be carried if they are to be taken by the individual transporting the drugs, he added. If individuals go through the proper processes, we can ensure the safe transport of necessary materials whilst protecting the borders, said Smith.

The Outsourcing in Clinical Trials Conference in New England held talks on several aspects of the US clinical research space with topics ranging from rare disease recruitment to international trial opportunities.